The leaders on the markets are very important to be followed, since there are several thousands of companies listed and it is hard to track all of them. The leaders in terms of volume are particularly important, because they reflect stocks which have the largest coverage and are the “stars” of the markets, so to speak. On Monday among these stocks are situated: General Electric Company (NYSE:GE), Facebook Inc (NASDAQ:FB), Intel Corporation (NASDAQ:INTC), Pfizer Inc. (NYSE:PFE), and SINA Corp (NASDAQ:SINA).
General Electric Company (NYSE:GE) picked down by 0.34% to $22.14 in deals worth $17.7 million. According to the New York Times, the lending arm of the General Electric Company (NYSE:GE), GE Capital has halted its consumer financing programs to retailers specialized in selling guns. “The lending cutoff applies only to retailers whose primary business is selling guns,” New York Times quoted spokesman, Russell Wilkerson.
Facebook Inc (NASDAQ:FB)‘s turnover amounted to almost $16.5 million, while the stock added 0.97% to $27.11. According to a filing with the Securities and Exchange Commission (SEC) issued on April 26, in the first quarter of 2012, the compensation committee accepted a request from Facebook Inc (NASDAQ:FB)’s CEO, Mark Zuckerberg to reduce his base salary to $1 per year, which began on January 1, 2013.
With a turnover of slightly above $15.9 million, Intel Corporation (NASDAQ:INTC) has appreciated by 1.54% to $23.76. According to an article in Intel Newsroom, Intel Corporation (NASDAQ:INTC) will release the fourth generation of the Intel Core processor family. “The new family of processors will surpass old technology expectations and usher in a host of striking new designs with incredible performance and extraordinarily long battery life,” the article also said.
Next on the list is Pfizer Inc. (NYSE:PFE), which gained 1.33% to $30.49 in deals worth $12.6 million. In a press release issued today, Merck & Co., Inc. (NYSE: MRK) said that it has reached a collaboration agreement with Pfizer Inc. (NYSE:PFE), under which both Merck & Co., Inc. (NYSE: MRK) and Pfizer will work on Pfizer Inc. (NYSE:PFE)’s ertugliflozin (PF-04971729), “an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.” “We are pleased to join forces with Merck in the battle against type 2 diabetes and the burden that it poses on global health, […] Through this collaboration, we believe we can build on Merck’s leadership position in diabetes care with the introduction of ertugliflozin, an innovative SGLT2 inhibitor discovered by Pfizer scientists,” the statement quoted the president and general manager of Pfizer Primary Care, John Young.
SINA Corp (NASDAQ:SINA) advanced by 10.32% to $55.49 in turnover worth almost $12.3 million. SINA Corp (NASDAQ:SINA) said today in a statement that it will form a strategic alliance between several entities affiliated with SINA Corp (NASDAQ:SINA) and some entities associated with Alibaba Group to look into social commerce and create innovative marketing solutions. The alliance is expected to bring about $380 millions in revenues from advertising and social commerce services.